Radiation and Cancer Biology

SS 08 - Biology 2 - Immune Biomarkers

8:00 AM - 9:00 AM
Location: Room W187

Session Type: Scientific
1.00 AMA PRA Category 1 Credits™
1.00 CAMPEP Credits


Mitchell Anscher, MD, FASTRO

Mitchell S Anscher

MD Anderson Cancer Center: Professor: Employee: Relationship ended 07/01/2019; US Food and Drug Administration: Medical Officer: Employee

MD Anderson Cancer Center: Research Grants: Relationship ended 07/01/2019

CivaTech Oncology: Stock: Relationship ended 05/15/2019

Virginia Life Sciences Investments: Member, Scientific Advisory Board: Relationship ended 03/15/2019

Mitchell S. Anscher, MD, FASTRO, FACR, FACRO
Professor Emeritus, Virginia Commonwealth University

Dr. Anscher received his MD from Virginia Commonwealth University and is board certified in both Internal Medicine and Radiation Oncology. His clinical focus has been primarily on the management of genitourinary malignancies, particularly prostate cancer. His clinical experience includes external beam radiation with both photons and protons, SBRT, hyperthermia and both LDR and HDR brachytherapy. His research interests focus primarily on clinical trials in the management of prostate cancer and both laboratory and translational/clinical studies focusing on normal tissue injury after cancer therapy. While on the faculty at Duke, Virginia Commonwealth University (where he was Professor and Florence and Hyman Meyers Chair of The Department of Radiation Oncology) and at the University of Texas MD Anderson Cancer Center (where he was Genitourinary Section Chief), he has had the pleasure and privilege to mentor numerous students, residents, fellows, graduate students, post-doctoral fellows and junior faculty, some of whom are still speaking to him.


Send Email for Mitchell Anscher

Ravi Patel, MD, PhD

University of Wisconsin

University of Wisconsin: Clinical Instructor: Employee

ASCO: Research Grants

Dr. Ravi Patel, M.D. Ph.D., is a Bentson Radiation Oncology Research Fellow in the Department of Human Oncology at the University of Wisconsin. He received his MD and Ph.D. (in biomedical engineering) from Case Western University, and clinical residency training at the University Hospitals Cleveland Medical Center training program. Dr. Patel is an aspiring physician-scientist who is currently completing a research fellowship in the labs of Dr. Paul Sondel and Dr. Zachary Morris studying the interaction of radiaton and immunotherapy. In particular, Dr. Patel has developed a treatment regimen combining low dose molecularly targeted unsealed source radionuclides with systemic immune checkpoint inhibitors (ICI), such as anti-CTLA4 and anti-PD1, to improve their efficacy in immunologically "cold" tumors that normally have poor response to ICI alone. An exciting aspect about this type of immunotherapy treatment approach is that it could potentially improve patient outcomes for a variety of cancers. In addition to his Benston Research Fellowship Award, Dr. Patel has also received the Radiological Society of North America Fellow Research Award and the Amercican Society of Clinical Oncology Young Investigator Award to study this important research question.


Send Email for Ravi Patel


SS 08 - Biology 2 - Immune Biomarkers

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for SS 08 - Biology 2 - Immune Biomarkers